| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |